Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5692578 | European Urology | 2016 | 7 Pages |
Abstract
Long-term results from this study indicate that some men will miss their chance of cure with active surveillance and it is questionable whether active surveillance is a suitable strategy for men who are not in the lowest tumor risk group and who have a very long remaining life expectancy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Rebecka Arnsrud Godtman, Erik Holmberg, Ali Khatami, Carl-Gustaf Pihl, Johan Stranne, Jonas Hugosson,